Cancer care in times of conflict: cross border care in Pakistan of patients from Afghanistan

• Published in: Ecancermedicalscience Vol. 14; p. 1018
• Main Authors: Yusuf, Muhammed Aasim, Hussain, Shoaib Fahad, Sultan, Faisal, Badar, Farhana, Sullivan, Richard
• Format: Journal Article
• Language: English
• Published: England Cancer Intelligence 2020
• Subjects: Adults; Cancer therapies; Chemotherapy; Displaced persons; Females; Gynecology; Health care; Hematology; Hospitals; Leukemia; Lymphoma; Medical diagnosis; Patients; Refugees; Registration; Kabul Afghanistan; Lahore Pakistan; Afghanistan; Pakistan; global health; migration; Afghanistan; cancer; Pakistan; conflict and health
• ISSN: 1754-6605; 1754-6605
• DOI: 10.3332/ECANCER.2020.1018

Armed conflict in Afghanistan has continued for close to 40 years and has devastated its health infrastructure. The lack of a cancer care infrastructure has meant that many Afghans seek cancer care in neighbouring countries, like Pakistan. There remains a significant lack of empirical data on the new therapeutic geographies of cancer in contemporary conflicts. This retrospective single centre study explores the therapeutic and clinical geographies of Afghan cancer patients who were treated at the Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC) in Lahore, Pakistan over a 22-year-period (1995 to 2017) covering major periods of conflict and relative peace. Data was available for 3,489 Afghan patients who received treatment at SKMCH&RC. The mean age at presentation was 42.7 years, and 60% were men. 30.2% came from Kabul and Nangarhar districts of Afghanistan, which have relatively short travel times to Pakistan, but patients from all parts of Afghanistan migrated to SKMCH&RC for treatment. Overall, 34.1% were diagnosed with upper gastrointestinal malignancies and 55.7% presented with late stage III/IV cancer. A wide range of treatments were provided, with 25.4% of patients receiving a combination of chemotherapy and radiation treatment. 52.7% of all patients were lost to follow-up. Outcomes were more favourable for children with cancer, 42% of whom had a complete response to therapy. Complex migration patterns, mixed political economies (refugees, forced and unforced migrants) and models of care that must be adapted to the realities of the patients rather than notional international standards all reflect the new therapeutic geographies that long-term conflict creates. This requires significant new domestic and international (e.g., United Nations High Commissioner for Refugees) policy and practises for providing cancer care in today's contemporary conflict ecosystems that frequently cross national borders.